Study of the mechanisms of crocetin-induced differentiation and apoptosis in human acute promyelocytic leukemia cells.

acute promyelocytic leukemia apoptosis crocetin differentiation multidrug resistance tyrosyl-DNA phosphodiesterase 1

Journal

Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 30 03 2018
accepted: 25 07 2018
pubmed: 12 9 2018
medline: 12 9 2018
entrez: 12 9 2018
Statut: ppublish

Résumé

Crocetin, the major carotenoid in saffron, exhibits potent anticancer effects. However, the antileukemic effects of crocetin are still unclear, especially in primary acute promyelocytic leukemia (APL) cells. In the current study, the potential antipromyelocytic leukemia activity of crocetin and the underlying molecular mechanisms were investigated. Crocetin (100 µM), like standard anti-APL drugs, all-trans retinoic acid (ATRA, 10 µM) and As

Identifiants

pubmed: 30203596
doi: 10.1002/jcb.27489
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1943-1957

Subventions

Organisme : Mashhad University of Medical Sciences

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Maliheh Moradzadeh (M)

Golestan Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Department of New Sciences and Technology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Ahmad Ghorbani (A)

Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran.

Saiedeh Erfanian (S)

Non-Communicable Diseases Research Center, Jahrom University of Medical Sciences, Jahrom, Iran.

Seyedeh Tahereh Mohaddes (ST)

Internal Medicine Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Hossein Rahimi (H)

Internal Medicine Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Ehsan Ghayoor Karimiani (EG)

Next Generation Genetic Clinic, Mashhad, Iran.

Baratali Mashkani (B)

Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Shih-Chieh Chiang (SC)

Department of Molecular Biology and Biotechnology, Krebs and Sheffield Institute of Nucleic Acids, University of Sheffield, Sheffield, UK.

Sherif F El-Khamisy (SF)

Department of Molecular Biology and Biotechnology, Krebs and Sheffield Institute of Nucleic Acids, University of Sheffield, Sheffield, UK.

Alijan Tabarraei (A)

Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Hamid Reza Sadeghnia (HR)

Department of New Sciences and Technology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Classifications MeSH